Neuphoria Therapeutics (NEUP) DMA 50 (2025 - 2026)

Neuphoria Therapeutics (NEUP) DMA 50 (2025 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	DMA 50
1	Alterity Therapeutics	814,307.08 Bn	814,307.05 Bn	-	4.24
2	Belite Bio	55,320.00 Bn	55,320.00 Bn	-	154.19
3	Quantum Biopharma	17,149.72 Bn	17,149.72 Bn	-	4.94
4	Legend Biotech	3,590.00 Bn	3,589.71 Bn	242.10 Mn	26.40
5	Akari Therapeutics	1,650.72 Bn	1,650.72 Bn	-	8.13
6	Evaxion A	1,522.09 Bn	1,522.07 Bn	-	4.07
7	Psyence Biomedical	229.39 Bn	229.38 Bn	-	4.92
8	Vertex Pharmaceuticals	113.09 Bn	105.85 Bn	2.59 Bn	436.72
9	Abivax	90.15 Bn	90.15 Bn	-	115.95
10	Neuphoria Therapeutics	23.86 Mn	4.46 Mn	-	4.93

Download Data